- Home
- Companies
- Magnolia Medical Technologies
- Products
- Steripath - Model Gen2 - Blood ...
Steripath - Model Gen2 -Blood Collection Devices
Steripath Gen2 is the simple, all-in-one solution clinically proven to reduce false positive blood culture results. Reduce your blood culture contamination rate to improve patient safety and key quality outcomes, while significantly reducing unnecessary antibiotic usage, length of stay and hospital costs.*
- FDA-cleared with an exclusive indication for reducing blood culture contamination¹
- Clinical & cost effectiveness studies published in CID, JEN, AJIC, JCM and JHI*
- Backed by a money-back, Clinical Performance Guarantee²
Steripath`s proprietary technology and easy-to-use design enable you to deliver the definitive diagnostic results your patients deserve
Evidence-Based Diversion Volume
1.5-2.0mL is the diversion volume clinically proven effective in peer-reviewed, published, controlled studies.³
Engineered Compliance
Uniquely designed to prevent the end-user from collecting the specimen until diversion is complete.
Secondary Collection Pathway
A secondary blood collection pathway automatically opens for specimen collection once diversion is complete.
User-Controlled Active Diversion
Gentle negative pressure assists in drawing the diverted blood, critical for hard stick patients.
Clinically Proven for IV Starts
Steripath has been clinically proven effective with peripheral IV starts and venipuncture.*
Available in a Customizable Kit
Everything you need to standardize blood culture collection best practices.